Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (NCT05202509)

🧪 Interventions in This Study

• Obicetrapib (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (591 Sites)

Showing the first 25 of 591 sites.

• Advanced Cardiovascular LLC — Alexander City, Alabama
• Ascension - Cardiology Specialists of Birmingham — Birmingham, Alabama
• Central Alabama Research — Birmingham, Alabama
• Cardiovascular Associates of the Southeast, LLC — Birmingham, Alabama
• Eastern Shore Research Institute, LLC — Fairhope, Alabama
• The Heart Center Research — Huntsville, Alabama
• Mobile Heart Specialists — Mobile, Alabama
• Syed Research Consultants — Muscle Shoals, Alabama
• Syed Research Consultants — Sheffield, Alabama
• Elite Clinical Studies — Phoenix, Arizona
• Clinical Research Institute of Arizona, LLC — Sun City West, Arizona
• Eclipse Clinical Research — Tucson, Arizona
• NEA Baptist clinic — Jonesboro, Arkansas
• Cardiology and Medicine Clinic — Little Rock, Arkansas
• Advanced Research Center — Anaheim, California
• Westside Medical Associates of Los Angeles — Beverly Hills, California
• Hope Clinical Research LLC — Canoga Park, California
• Titan Medical Research - Oceanside — Encinitas, California
• Clinical Trials Research — Lincoln, California
• Torrance Clinical Research Institute Inc. — Lomita, California
• American Institute of Research — Los Angeles, California
• Amicis Research Center-Northridge — Northridge, California
• Amicis Research — Northridge, California
• Valley Clinical Trials, Inc — Northridge, California
• Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Atherosclerotic Cardiovascular Disease

• A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease — Boston, Massachusetts
• VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease — Birmingham, Alabama
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Birmingham, Alabama
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Birmingham, Alabama
• Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE — Memphis, Tennessee

Explore by condition: All Atherosclerotic Cardiovascular Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.